Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Hyloris Pharmaceuticals

    MCap

    EUR120m

    Last close

    EUR4.25

    ▲ 0.76 (21.78%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    Actinogen Medical

    MCap

    AUD186m

    Last close

    AUD0.05

    ▲ 0.01 (17.07%)

  • Sectors

    Sectors

    View All Sectors
  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Sparks commentary - Mendus

Healthcare

Sparks - Mendus

More on this equity
Mendus_resized
Mendus (OMX: IMMU) expands NK cell therapy manufacturing with NorthX
Published by Arron Aatkar, PhD

Mendus has secured a SEK 977,300 grant from Swedish innovation agency, Vinnova, to expand its manufacturing collaboration with NorthX Biologics into memory natural killer (NK) cell therapies, adding a potential new treatment approach for acute myeloid leukaemia (AML). The funding, awarded through a competitive life sciences infrastructure programme, will support the establishment of a manufacturing platform using Mendus’ proprietary DCOne technology to produce memory NK cells from healthy donors. These specialised immune cells have demonstrated sustained anticancer activity, with evidence linking their presence after stem cell transplantation to lower relapse rates.

The initiative builds on the partners’ existing manufacturing alliance for lead asset vididencel, established in 2023. We view the expansion as a positive step towards broadening Mendus’ immunotherapy capabilities, with the immediate focus on establishing manufacturing ahead of further therapeutic development.

Next Sparks Commentary in this sector >

Latest

Consumer | Comment

Bally’s Intralot (BYLOT:ASE) Q326 revenue and profitability increase versus Q226

Industrials | Comment

Avon Technologies (LSE: AVON) – strong FY26 delivery supports continued growth into FY27

Industrials | Comment

The Metals Company (NASDAQ: TMC) – NOAA final determination on TMC USA’s certification expected by mid-December 2026

TMT | Comment

Kainos (LSE: KNOS): Firing on all cylinders in H127

Healthcare | Comment

Starpharma (ASX: SPL) targets December start for DEP HER2-Lu trial
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.